Bone Biologics Announces Closing of $2.0 Million Public Offering

Stock Information for Longeveron Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Longeveron Inc.

Bone Biologics Appoints Phillip T. Meikle to its Board of Directors
Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
First Two Patients Treated in Pilot Clinical Study with Bone Biologics' NB1 Bone Graft Device in Spine Fusion
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
Bone Biologics Executives to be Interviewed in a "CEO Chat" by Zacks Small-Cap Research Analyst on June 20th
Bone Biologics Announces Pricing of $2.0 Million Public Offering

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.